No Data
No Data
Atossa Therapeutics Announces Recognition of Breast Cancer Awarenss Month
Domino's Pizza To $510? Here Are 10 Top Analyst Forecasts For Wednesday
Express News | Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $6.5
Atossa Therapeutics Analyst Ratings
Atossa Therapeutics Announces Support of Final Rule From FDA Requiring Patient Notification of Breast Density, a Critical Step in Addressing a Known Risk Factor for Breast Cancer
Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference